{
  "ptid_time": "116_S_4625_2012-06-28",
  "img_path": "/data/qiuhui/data/adni/images/116_S_4625/2012-06-28/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 30,387 mm³, 1.2% above the reference mean. With a Z-score of 0.03 (51.1th percentile), this represents normal volume ; hippocampal volume measures 8,158 mm³, 1.6% above the reference mean. With a Z-score of 0.16 (56.5th percentile), this represents normal volume ; whole brain volume measures 1,071,950 mm³, 5.5% below the reference mean. With a Z-score of -0.78 (21.7th percentile), this represents normal volume . ",
  "text_data": "Age is 63.8 years. Gender is Male. Education: 16 years. Handedness: Left. Race: More than one race. Medical history: Psychiatric; Head, Eyes, Ears, Nose and Throat; Cardiovascular; Respiratory; Dermatologic-Connective Tissue; Musculoskeletal; Endocrine-Metabolic; Allergies or Drug Sensitivities; Malignancy; Major Surgical Procedures. MMSE: 22.0. MoCA: 21.0. Logical Memory: 0.0. APOEε4 alleles: 2.0. Biomarker levels: Florbetapir (AV45): 1.63 SUVR (profound elevated); Amyloid beta: 366.30 pg/mL (moderate reduced); Total tau: 342.40 pg/mL (mild elevated); Phosphorylated tau: 36.69 pg/mL (moderate elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The patient shows normal brain volumes (ventricular, hippocampal, and whole brain) but has significant biomarker abnormalities (moderately reduced Aβ, mildly elevated T-tau, moderately elevated P-tau, and profoundly elevated AV45). Cognitive testing (MMSE 22, MoCA 21) suggests mild impairment, and the presence of two APOE4 alleles increases Alzheimer's risk.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely due to Alzheimer's pathology)  \n**Confidence:** **High** (due to biomarker profile and cognitive scores, despite normal brain volumes)",
  "timestamp": "2025-07-26T12:12:48.993385"
}